Their work has revealed that the concentration of IL-2, IL-6, IL-8 and IL-10 in the plasma influenced the survival of these patients, and the measurement of these parameters may be a useful biomarker to estimate the risk of developing PAH [46]. The gene discussed is IL2; the disease is pulmonary arterial hypertension.